The clinical trial will evaluate the PerQdisc device for patients suffering from degenerative disc disease, according to a March 4 news release. The system is an alternative to spinal fusion and disc replacement.
Spinal Stabilization Technologies said it raised $17 million from new and existing investors to support the trial and advance other clinical initiatives.
Additionally, the company added Frank Phillips, MD, to its Board of Directors. Dr. Phillips is a renowned spine surgeon with several patents and more than 200 publications. He has also pioneered minimally invasive procedures and launched several spine companies.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
